Journey Medical (DERM) Return on Invested Capital (2022 - 2025)

Journey Medical's Return on Invested Capital history runs 3 years deep, the most recent figure standing at 0.01% for Q4 2025.

• Quarterly Return on Invested Capital changed N/A year-over-year to 0.01% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.01% (changed N/A YoY) and the FY2022 annual result came in at 0.15%, changed N/A from the prior year.
• Return on Invested Capital was 0.01% for Q4 2025 at Journey Medical, down from 0.01% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.0% in Q4 2023 and bottomed at 0.46% in Q1 2022.
• A 3-year average of 0.16% and a median of 0.02% in 2025 frame the typical range for Return on Invested Capital.
• Peak annual rise in Return on Invested Capital reached 41 bps in 2023, while the deepest fall reached 15 bps in 2023.
• Journey Medical's Return on Invested Capital stood at 0.15% in 2022, then jumped by 99 bps to 0.0% in 2023, then slumped by 611 bps to 0.01% in 2025.
• Business Quant data shows DERM's Return on Invested Capital at 0.01% in Q4 2025, 0.01% in Q3 2025, and 0.02% in Q2 2025.